News | April 21, 2022
Agilent joins the National Institute for Innovation in Manufacturing to advance biomanufacturing
Support for biologics manufacturability and Industry 4.0 initiatives
Support for biologics manufacturability and Industry 4.0 initiatives
The approval of this important test marks the 14th IVD to receive clearance by the CDSCO, and strengthens the company’s foundation for future growth
Strive to empower public health with disinfection robotics solutions in post-pandemic era
The purpose of the study is to investigate safety and tolerability of SNIPR001 in healthy volunteers and to evaluate the effect of SNIPR001 on reducing E. coli colonization in the gut
By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
Bionova Scientific’s process development capabilities are particularly highly regarded in the industry, and it has a rich track record regarding complex next-generation antibody drugs, which are typically challenging to manufacture
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
Subscribe To Our Newsletter & Stay Updated
